Täältä voit lukea lisää tutkimuksista, joihin olemme osallistuneet ja joita olemme rahoittaneet vuosien varrella. Löydät eri määrärahat valikosta.

Säätiö tukee alueensa eturintamassa olevaa tutkimusta. Tutkimushankkeet, joille myönnetään tutkimusapurahaa, valitaan neuvoa-antavasta komiteassa. Miten prosessi menee, voit lukea lisää Täältä

Haluatko tukea tutkimusta?

Tukemalla meitä autat diabeteksen torjunnassa. Tukeasi tarvitaan, jotta voimme tukea diabetestutkimuksia, joilla uskomme olevan parhaat edellytykset saada aikaan parempia hoitomuotoja sekä tyypin 1 että tyypin 2 diabetekseen. Perimmäinen tavoitteemme on löytää parannuskeino diabetekseen, mutta myös lisätä tietoutta sairaudesta ja sen komplikaatioista.

Lahjoita

2023

Dr Niina Matikainen, Helsinki University

10 000 EUR

Contribution of postprandial triglyceride-rich lipoproteins to the increased residual CVD risk during statin treatment in Type 2 Diabetes

Dr Kaisa Ivaska, University of Turku

10 000 EUR

Bone marrow adiposity in the pathophysiology of Type 2 Diabetes

Dr Constanze Schmot, Helsinki University

10 000 EUR

Targeting fluid flow shear stress-induced cell injury in diabetic kidney disease

Dr Rim Bouslama Helsinki University

10 000 EUR

Unravelling a new tie between inflammation and diabetic kidney disease

Ms Inna Starskaia, University of Turku

10 000 EUR

Early immune response in children en route to type 1 diabetes to provide insights into the heterogeneity of the disease

2021

2020

Dr Olof Eriksson, Uppsala University

10 000 EUR

GPR44 as a PET marker for measuring beta cell mass in human

Professor Anders Tengholm, Uppsala University

10 000 EUR

Rap and Ras signalling in insulin secretion

2019

Professor Vesa Olkkonen, University of Helsinki

40 000 EUR

Delineating novel mechanisms of human adipocyte lipid metabolism in typs 2 diabetes and insulin resistance;miR-221-3p as a bait

2018

2017

2016

Mr Nagendra Yaluri, University of Eastern Finland

6 000 EUR

Diabetogenic effects of statins

Dr Jonna Saarimaki-Vire, University of Helsinki

10 000 EUR

Importance of cell-cell interactions and heterogeneity in human pluripotent stem cell-derived islet-like clusters to model diabetes

Mr Shalem Raju Modi, University of Eastern Finland

6 000 EUR

Novel treatments for type 2 diabetes via SIRT1 activation and regulation of insulin sensitivity in muscle and adipose tissues

Dr Aila Ahola, Folkhalsan Institute of Genetics

10 000 EUR

The association between self-management of type 1 diabetes and diabetic complications – Finnish Diabetic Nephropathy (FinnDiane) Study

Dr Riikka Kivela, University of Helsinki

10 000 EUR

Transcription factor Prox1 – a potent regulator of glucose metabolism?

Miss Maria Vahatupa, University of Tampere

10 000 EUR

Vascular homing peptide CAR in pathological retinal angiogenesis and CAR-decorin in ocular fibrosis in mouse

2015

Tero Jarvinen Medical School, University of Tampere

10 000 EUR

Enhanced wound healing in diabetes by wound homing, cell penetrating peptide induced syndecan-4 dependent cell migration

Sanna Lehtonen, University of Helsinki

10 000 EUR

Identification of small molecules that enhance beta cell proliferation and differentiation

Diego Balboa, University of Helsinki

10 000 EUR

In vitro maturation of stem cell derived pancreatic beta cells for diabetes research grant

Maarit Lehti, LIKES Foundation, Jyvaskyla

10 000 EUR

Significance of HDL-C on energy metabolism in type 2 diabetes

Essi Havula, University of Helsinki

10 000 EUR

Transcriptional control of dietary sugar metabolism and homeostasis

2014

Dr Satu Pekkala, University of Turku

10 000 EUR

Development of Novel Treatment Strategies for Type 2 Diabetes and non-Alcoholic Fatty Liver Disease based on gut microbiota

Dr Tiinamaija Tuomi, University of Helsinki

10 000 EUR

FINNMODY - Monogenic diabetes in Finland

Dr Arno Hänninen, University of Turku

10 000 EUR

The role of gut microbiota and Akkermansia muciniphila in protection against autoimmune (type 1) diabetes

2013

PhD Diana Toivola, Åbo Akademi Turku

5 000 EUR

Keratin intermediate filament as regulators in the endocrine pancreas

M.Sc. Ph.D researcher Niyas K Saleem, Itä-Suomen Yliopisto

5 000 EUR

MicroRNAs are as Emerging Biomarkers for Type 2 Diabetes and Metabolic Syndrome

M.D. PhD Hänninen, Arno Lauri Mikael, Turun Yliopisto

5 000 EUR

Probiotic bacteria in the prevention of type 1 diabetes in the NOD mouse

Amirbabak Sioofy-Khojine, Tammerfors Universitet

5000 EUR

Bidrag för att kunna jobba med Malin Flodström Tullberg vid Karolinska Institutet

2012

Havula Essi, filosofian maisteri, Helsingin University

5 000 EUR

Genetic mechanisms in cellular sugar sensing and metabolism

Hakkola Jukka, professori, Oulun University

5 000 EUR

Metformiinin molekyylivaikutukset maksassa

Putaala Jukka, lääketieteen tohtori, Helsingin University

5 000 EUR

Subclinical risk factors for cerebrovascular disease in patients with T1D: A longitudinal long-term follow-up study

Toivola Diana, professori, Åbo Akademi Turku

5 000 EUR

The role of keratin intermediate filaments for the function of pancreatic islets and type I diabetes